The inhibitory checkpoint molecule NKG2A is upregulated on tumor-infiltrating NK cells and CD8 T-cells in human head and neck tumors

被引：1
|
作者：
Korrer, Michael J. [1 ]
Kim, Young [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-A198
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A198
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The inhibitory checkpoint molecule NKG2A is upregulated on tumor infiltrating NK cells and CD8 T cells in human head and neck tumors
    Korrer, Michael
    Kim, Young
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [2] NKG2A checkpoint receptor expression on tumor-infiltrating CD8+ T cells restrains efficacy of immunotherapy
    van Hall, Thorbald
    van Montfoort, Nadine
    Piersma, Sytse
    Sluijter, Marjolein
    Welters, Marij J.
    Andre, Pascale
    Wagtmann, Nicolai
    van der Burg, Sjoerd H.
    CANCER RESEARCH, 2017, 77
  • [3] The inhibitory receptor NKG2A acts as a checkpoint on CD8 T cells in the context of cancer vaccines.
    van Hall, Thorbald
    van Montfoort, Nadine
    Borst, Linda
    Korrer, Michael J.
    Kim, Young
    Andre, Pascale
    Wagtmann, Nicolai
    Piersma, Sytse
    van der Burg, Sjoerd H.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 81 - 81
  • [4] IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cells
    Fesneau, Olivier
    Samson, Kimberly A.
    Rosales, Wesley
    Jones, Bretton
    Moudgil, Tarsem
    Fox, Bernard A.
    Rajamanickam, Venkatesh
    Duhen, Thomas
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [5] A Radiomic Surrogate to Predict Tumor-Infiltrating CD8 T-Cells in Soft Tissue Sarcoma
    Schaub, S. K.
    Spraker, M. B.
    Hippe, D. S.
    Wootton, L.
    Peeken, J. C.
    Combs, S. E.
    Blumenschein, W.
    McClanahan, T. K.
    Kinahan, P. E.
    Kim, E. Y.
    Kim, T.
    Pollack, S.
    Nyflot, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E2 - E3
  • [6] NKG2A expression on tumor reactive CD8 T cells is induced by IL-12
    Fesneau, Olivier
    Rosales, Wesley
    Samson, Kimberly
    Rajamanickan, Venkatesh
    Haugh, William
    Huang, Jianguo
    Duhen, Thomas
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [7] NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division
    Borst, Linda
    Sluijter, Marjolein
    Sturm, Gregor
    Charoentong, Pornpimol
    Santegoets, Saskia J.
    Gulijk, Mandy
    van Elsas, Marit J.
    Groeneveldt, Christianne
    van Montfoort, Nadine
    Finotello, Francesca
    Trajanoski, Zlatko
    Kielbasa, Szymon M.
    van der Burg, Sjoerd H.
    van Hall, Thorbald
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (04) : 688 - 704
  • [8] Cytolytic activities of inhibitory NK cell receptor (CD94/NKG2A)-expressing CD8 T cells expanded by different cytokines
    Tanaka, J.
    Sugita, J.
    Kato, N.
    Toubai, T.
    Ibata, J.
    Shono, Y.
    Ota, S.
    Asaka, M.
    Imamura, M.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 40 - 40
  • [9] Metabolic dysfunction and DNA damage of exhausted tumor-infiltrating CD8 T-cells in hepatocellular carcinoma
    Montali, A.
    Reverberi, V.
    Dalla Valle, R.
    Boni, C.
    Fisicaro, P.
    Vecchi, A.
    Rossi, M.
    Doselli, S.
    Berti, C. Ceccatelli
    Tiezzi, C.
    Montali, I.
    Ferrari, C.
    Missale, G.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S213 - S213
  • [10] The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells
    Kaulfuss, Meike
    Mietz, Juliane
    Fabri, Astrid
    vom Berg, Johannes
    Munz, Christian
    Chijioke, Obinna
    SCIENTIFIC REPORTS, 2023, 13 (01)
12345